Published in Heart Vessels on July 31, 2010
Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels (2011) 1.04
Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases. Heart Vessels (2011) 0.94
Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels (2011) 0.83
Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention. Heart Vessels (2011) 0.81
Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis. Heart Vessels (2012) 0.81
A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator. Heart Vessels (2015) 0.80
Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study. Heart Vessels (2012) 0.75
Acidic urine is associated with poor prognosis in patients with chronic heart failure. Heart Vessels (2012) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet (2005) 6.59
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation (2002) 4.30
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31
Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J (2005) 3.09
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol (2002) 2.97
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74
Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol (2004) 2.69
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol (2000) 2.52
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol (2001) 2.45
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20
Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int (2005) 1.96
Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol (2001) 1.65
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol (2000) 1.64
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension (2008) 1.54
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol (2003) 1.27
Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol (2001) 1.18
Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a study in Fukuoka, Japan. Jpn Circ J (2000) 1.11
Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J (2006) 0.95
The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant (2003) 0.89
The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? J Nephrol (2004) 0.87
Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J (2008) 0.85
Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes: the GREECS study. Circ J (2007) 0.85
Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes. Heart Vessels (2008) 0.82
The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events. Heart Vessels (2008) 0.81
Anemia in chronic kidney disease and congestive heart failure. Blood Purif (2003) 0.79
Anaemia and heart failure. Heart (2004) 0.78
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol (2009) 5.70
Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol (2007) 2.97
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood (2005) 2.90
Human C-reactive protein does not promote atherosclerosis in transgenic rabbits. Circulation (2009) 2.83
Takotsubo cardiomyopathy with involvement of delayed-onset rhabdomyolysis and acute kidney injury after rosuvastatin treatment. Intern Med (2015) 2.64
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem (2007) 2.44
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging (2013) 2.31
Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART). J Am Coll Cardiol (2002) 2.26
The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem (2007) 2.24
Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease. Circ J (2010) 2.13
Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J (2009) 2.01
Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem (2010) 1.77
Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging (2012) 1.77
Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci (2007) 1.64
Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. J Am Coll Cardiol (2004) 1.55
Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun (2002) 1.53
Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes. Circ Cardiovasc Interv (2011) 1.51
Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis (2012) 1.51
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res (2003) 1.46
Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure. Heart Rhythm (2007) 1.45
Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med (2003) 1.44
Multimarker approach to risk stratification for long-term mortality in patients on chronic hemodialysis. Circ J (2015) 1.41
Morphologic and functional assessment of coronary artery disease--potential application of computed tomography angiography and myocardial perfusion imaging. Circ J (2012) 1.41
High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol (2005) 1.41
Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J (2012) 1.38
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2008) 1.37
Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke (2008) 1.29
Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study. Circ J (2008) 1.29
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2009) 1.28
Function and role of microparticles in various clinical settings. Thromb Res (2008) 1.28
Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis (2009) 1.25
Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem (2012) 1.20
Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood (2005) 1.19
Sphingosine 1-phosphate-related metabolism in the blood vessel. J Biochem (2005) 1.18
Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ann Clin Biochem (2008) 1.17
Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J (2007) 1.15
Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol (2002) 1.15
Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging (2010) 1.12
Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem (2005) 1.11
Relationships between plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb (2010) 1.11
Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase. Blood (2002) 1.09
Involvement of Src kinases and PLCgamma2 in clot retraction. Thromb Res (2006) 1.09
Expression of the LIM proteins paxillin and Hic-5 in human tissues. J Histochem Cytochem (2003) 1.08
Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation. Circ J (2007) 1.08
Role of myocardial interstitial edema in conduction disturbances in acute myocarditis. Heart Vessels (2006) 1.04
Cystatin C in acute heart failure without advanced renal impairment. Am J Med (2009) 1.03
Global trend in overweight and obesity and its association with cardiovascular disease incidence. Circ J (2014) 1.02
More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study. J Atheroscler Thromb (2010) 0.99
Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study. Cardiovasc Diabetol (2013) 0.99
Redundant mechanism of platelet adhesion to laminin and collagen under flow: involvement of von Willebrand factor and glycoprotein Ib-IX-V. J Biol Chem (2008) 0.99
Cardiovascular disease mortality and serum carotenoid levels: a Japanese population-based follow-up study. J Epidemiol (2006) 0.98
Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost (2005) 0.98
Prognostic implications of left ventricular wall motion abnormalities associated with subarachnoid hemorrhage. Int Heart J (2008) 0.98
Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity. Ann Clin Biochem (2008) 0.95
Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis (2008) 0.95
Risk factors for patients developing a fulminant course with acute myocarditis. Circ J (2004) 0.95
The role of catecholamines in the pathogenesis of neurogenic pulmonary edema associated with subarachnoid hemorrhage. Acta Neurochir (Wien) (2012) 0.95
Noninvasive coronary angiography with a prototype 256-row area detector computed tomography system: comparison with conventional invasive coronary angiography. J Am Coll Cardiol (2008) 0.94
A population-based follow-up study on mortality from cancer or cardiovascular disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants. Asian Pac J Cancer Prev (2007) 0.93
Changes in the peripheral eosinophil count in patients with acute eosinophilic myocarditis. Heart Vessels (2003) 0.93
Chromene and prenylated xanthones from the roots of Cratoxylum formosum ssp. pruniflorum. Chem Pharm Bull (Tokyo) (2010) 0.93
Arsenic adsorption from aqueous solution on synthetic zeolites. J Hazard Mater (2008) 0.92
Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study. Cerebrovasc Dis (2007) 0.92
Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem (2003) 0.92
Podoplanin expression in advanced atherosclerotic lesions of human aortas. Thromb Res (2012) 0.92
The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. J Atheroscler Thromb (2010) 0.90
Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis. J Pathol (2005) 0.89
Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure. Circ J (2007) 0.89